NDAORALTABLET
Approved
Oct 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IOSAT (potassium iodide) is an oral tablet indicated for thyroid protection during nuclear emergencies and radioactive iodine exposure. It works by saturating the thyroid with stable iodide, blocking uptake of radioactive iodine-131. This is a critical public health countermeasure positioned in emergency preparedness.
LOE Approaching
As a product with lifecycle approaching loss of exclusivity and moderate competitive pressure (30%), the brand team is likely focused on maintaining market position in emergency preparedness channels rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities on IOSAT are concentrated in manufacturing, facilities, and operations roles rather than commercial or medical functions, reflecting its mature product status and small commercial footprint. This profile indicates a stable but limited career ladder; professionals should expect roles focused on production continuity and regulatory compliance.
ELECTRICIAN
Worked on IOSAT at Mission Pharmacal? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.